BECTON DICKINSON & CO — Director's Dealing 2020

Jun 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2020-06-01

Reporting Person: Kaltenbach Patrick (EVP & Pres Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-01	Common Stock	F	400	—	Disposed	14910	Direct
2020-06-02	Common Stock	S	222	$244.83	Disposed	14688	Direct

Footnotes

F1: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I.

F2: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $244.83 through $244.91. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 13, 2019.